The breast cancer cell lines MDA-MB-453 and SKBR are HER2-positive and estrogen receptor/progesterone receptor-negative, while MDA-MB-231 is triple-negative regarding Her-2/neu protein, estrogen, and progesterone expression (Holliday and Spairs, 2011). Here, ERBB2 is linked to breast carcinoma.